Results with Optilume consistent in clinical trials and real world, regardless of prostate ...

Image courtesy of Prodeon Medical] Prodeon Medical announced today that it received FDA 510(k) clearance for its Urocross ...

MINNEAPOLIS, March 5, 2026 /PRNewswire/ -- Francis Medical, Inc., a privately held medical device company, announced today the successful completion of the first commercial (non-clinical trial) ...

This week, cancer researchers in New York are one step closer to answering a question that has plagued medical and environmental advocates for decades: What is the role of plastic exposure in the ...

He began experiencing issues with urination, but was cleared of prostate cancer and initially did not take action. Benign prostatic hyperplasia, also called an enlarged prostate, affects about 50 per ...

In a new study, researchers found microplastics deep inside prostate cancer tumors, raising more questions about the role the ubiquitous pollutants play in public health. The findings — which come ...

The Urocross Expander System is designed to remodel the obstructing prostatic lobes during the six-month indwell time and is intentionally retrieved, leaving no permanent foreign material behind.